Command Palette
Search for a command to run...
Vijaya Diagnostic Centre
NSE: VIJAYABSE: 543350HEALTHCAREHEALTHCARE SERVICES
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre, established in 1981, operates an integrated model combining pathology and radiology services, including pathological tests and advanced imaging such as nuclear medicine. The company provides diagnostic services to customers including individuals, hospitals, corporate clients, and other healthcare providers. Vijaya Diagnostic offers home sample collection services, providing diagnostics at customers' doorsteps, and corporate wellness solutions, including onsite and offsite health check-ups. It operates in over 6 states in India including Telangana, Andhra Pradesh, Maharashtra, Karnataka, West Bengal, and Delhi NCR.
Vijaya Diagnostic Centre Limited established in 1981, is a leading provider of diagnostic services in India. With a steadfast commitment to delivering high quality, comprehensive diagnostic solutions, Vijaya has grown into the largest integrated diagnostic chain in Southern India. Founded by Dr. S. Surendranath Reddy, the journey began to offer reliable and comprehensive diagnostic services under one roof. Today, Company operate a vast network of 151+ diagnostic centres across 25+ cities, including Telangana, Andhra Pradesh, Maharashtra, Karnataka, West Bengal and the National Capital Region. Their state-of-the-art facilities are equipped with the latest technology, to offer a wide range of pathology and radiology services. Company provides Corporate Wellness solutions. These corporate wellness solutions include onsite and offsite health check-ups. It works a corporate client base consisting of more than 450 multinational corporations operating in India. Corporate wellness solutions help ensure that a brand's workforce is always at the peak of its health, thereby enhancing business productivity. Vijaya Diagnostic Centre Limited was incorporated as 'Vijaya Diagnostic Centre Private Limited' on June 5, 2002 as a Private Limited Company, which subsequently converted the status into a Public Company and the name of the Company was changed to Vijaya Diagnostic Centre Limited on 26 March, 2021. The company came out with an Rs 1895.04-crore public issue during the month of September 2021, comprised 35688064 equity shares of Re 1 each at a price of Rs 531 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 14 September 2021. The Company became first independent diagnostic centre in Telangana to get Revolution ACT 50 slice CT from Wipro GE Healthcare Private Limited in 2021. It opened 15 centres in 2021-22. In 2023-24, Company acquired 100% equity stake in P H Diagnostic Centre Private Limited making it a wholly owned subsidiary of the Company effective from December 21, 2023. In Pune, the acquisition of P.H. Diagnostics enabled rapid scale-up through its wide range of centres. Company launched 2 new centres in Bengaluru in FY 2025. It operationalized first state-of-the-art-centre in Ambegaon, Pune under the brand name Vijaya-PH in FY 2025. Medinova Diagnostic Services Limited (MDSL) has been merged with the Company in June, 2024.
Price Action • VIJAYA
Financial Statements
Consolidated & Standalone Reports
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 703.55 | 646.44 | 546.46 | 464.15 | 463.8 | 378.15 | 340.44 | 287.72 | 243.63 | 212.58 | 163.14 | 9.25 |
Operating Expenses | 405.8 | 374.63 | 312.83 | 270.61 | 251.02 | 204.02 | 196.2 | 184.94 | 158.34 | 142.12 | 105.53 | 6.62 |
Operating Profit | 274.51 | 252.51 | 212.2 | 178.97 | 199.86 | 163.3 | 132.45 | 94.13 | 79.54 | 67.14 | 55.15 | 2.63 |
Operating Margin (%) | - | 39.06 | 38.83 | 38.56 | 43.09 | 43.18 | 38.91 | 32.72 | 32.65 | 31.59 | 33.81 | 28.4 |
Total Expenses | - | 464.11 | 391.94 | 352.88 | 319.42 | 268.56 | 258.69 | 215 | 185.45 | 168.48 | 127.67 | 8.8 |
EBITDA | - | 271.81 | 233.64 | 193.54 | 212.77 | 174.13 | 144.24 | 102.77 | 85.29 | 70.46 | 57.61 | 2.64 |
EBITDA Margin (%) | - | 42.05 | 42.75 | 41.7 | 45.88 | 46.05 | 42.37 | 35.72 | 35.01 | 33.15 | 35.31 | 28.49 |
Interest Expenses | 26.96 | 24.96 | 23.71 | 20.88 | 16.26 | 14.81 | 14.82 | 4.36 | 4.14 | 4.76 | 3.45 | 0.36 |
Depreciation | 71.69 | 64.52 | 55.41 | 61.39 | 52.14 | 49.73 | 47.67 | 25.69 | 22.97 | 21.6 | 18.69 | 1.82 |
Profit Before Tax (PBT) | 198.08 | 181.3 | 152.47 | 111.27 | 144.38 | 109.59 | 81.75 | 70.41 | 55.59 | 44.1 | 35.47 | 0.45 |
Tax Expenses | 50.34 | 46.29 | 37.87 | 28.04 | 36.28 | 26.76 | 20.51 | 21.49 | 20.2 | 20.24 | 8.68 | 0.39 |
PAT Before Extraordinary Items | - | 135.01 | 114.6 | 83.23 | 108.1 | 82.82 | 61.24 | 48.92 | 35.4 | 23.86 | 26.79 | 0.07 |
Net Profit | 147.74 | 135.01 | 114.6 | 83.23 | 108.1 | 82.82 | 61.24 | 48.92 | 35.4 | 23.86 | 26.79 | 0.07 |
Net Profit Margin (%) | - | 21.52 | 21.82 | 18.51 | 23.97 | 22.54 | 18.63 | 17.52 | 14.88 | 11.4 | 16.66 | 0.71 |
EPS (Adjusted) | - | 13.12 | 11.14 | 8.09 | 10.51 | 8.05 | 5.95 | 4.75 | 3.44 | 2.32 | 2.6 | 0.01 |
Valuation & Key Ratios
Performance Metrics
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Book Value Per Share | - | 76.34 | 63.83 | 53.4 | 46.09 | 795.58 | 612.33 | 476.9 | 363.38 | 288.68 | 136.96 | -35.62 |
Return on Assets (ROA) % | - | 11.03 | 11.91 | 9.79 | 15.2 | 15.54 | 12.88 | 16.73 | 15.82 | 12.7 | 20.74 | 1.27 |
Return on Equity (ROE) % | - | 17.23 | 17.54 | 15.26 | 23 | 22.97 | 22.06 | 22.64 | 21.51 | 18.25 | 44.63 | -0.92 |
Return on Capital Employed (ROCE) % | - | 19.35 | 19.88 | 16.82 | 24.8 | 25.16 | 22.82 | 30.69 | 32.17 | 30.99 | 42.75 | -25.86 |
Profitability Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Liquidity Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Valuation Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Debt to Equity Ratio | - | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.13 | 0.12 | 0.18 | 0.55 | -0.12 |
Featured Insight
No recent news available
Key People
H
Hansraj Singh
Company Secretary,Compliance Officer
S
Sura Suprita Reddy
Executive Director,Managing Director,Chief Executive Officer
M
Mr. S Ramchandra Reddy
Chief Financial Officer